KatieB Posted August 31, 2018 Share Posted August 31, 2018 Quote GlaxoSmithKline (GSK) wishes to understand the perspective of advanced-stage NSCLC patients who may potentially receive any cell-based therapies (such as CAR-T or TCR therapies). They are specifically looking to speak with Patients: · With metastatic NSCLC who have NOT received cell therapy but other treatments such as chemotherapy · Patients who are planning to receive any cell-based therapies in the near future for metastatic NSCLC This research will consist of completing a short pre-interview worksheet and then participating in a brief, 45-minute web-assisted telephone call. The research discussions will be scheduled to take place over the phone/WebEx in the month of October, 2018 based on availability. For your time and valuable opinions, you may be compensated if you qualify, please contact Prani Paka at prani.8.paka@gsk.com for more information Quote Link to comment Share on other sites More sharing options...
Recommended Posts